Kolexia
Doyen Jerome
Oncologie radiothérapie
Centre Antoine Lacassagne
Nice, France
231 Activités
1.2 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du rectum Tumeurs du poumon Carcinomes Carcinome pulmonaire non à petites cellules Récidive tumorale locale Métastase tumorale Carcinome épidermoïde Carcinome pulmonaire à petites cellules Tumeurs de la tête et du cou

Industries

AstraZeneca
4 collaboration(s)
Dernière en 2021
MSD
2 collaboration(s)
Dernière en 2023
B3TSI
2 collaboration(s)
Dernière en 2021
Merck-Serono
1 collaboration(s)
Dernière en 2023

Dernières activités

Onvansertib in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer Patients With a Kras Mutation: A Phase 1b/2 Study of Onvansertib (PCM-075) in Combination With FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Patients With a Kras Mutation
Essai Clinique (Cardiff Oncology)   29 février 2024
Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: A French retrospective study.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   16 février 2024
ICAR: Phase I Trial of Carbonic Anhydrase Inhibition Associated With Platinum-based Chemotherapy and Etoposide in Concomitance With Radiotherapy in Localized Small Cell Lung Carcinomas
Essai Clinique (Centre Antoine Lacassagne)   09 février 2024
NIRVANA-LUNG: PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
Essai Clinique (Unicancer)   11 décembre 2023
BEPCOME-MB: Randomised Phase 2 Trial Testing the Addition of Upfront Stereotactic Radiosurgery to Binimetinib Encorafenib Pembrolizumab Compared to Binimetinib Encorafenib Pembrolizumab Alone in BRAFV600 Mutation-positive Melanoma With Brain Metastasis
Essai Clinique (Merck & Co.)   29 novembre 2023
NIRVANA: Nivolumab in Combination With High Dose Radiotherapy at Varied Tumor Sites in Advanced Melanoma and no Prior Antitumoral Treatment
Essai Clinique (CHU Nice)   14 novembre 2023
Proton versus photon therapy for esophageal cancer - A trimodality strategy (PROTECT) NCT050555648: A multicenter international randomized phase III study of neoadjuvant proton versus photon chemoradiotherapy in locally advanced esophageal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   05 novembre 2023
EUROPEAN CLINICAL PRACTICE IN PENCIL BEAM SCANNING PROTON THERAPY FOR PEDIATRIC POSTERIOR FOSSA TUMORS
Abstracts from the 55th Congress of the International Society of Paediatric Oncology (SIOP) October 11–14, 2023   02 novembre 2023
Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Study of PCM-075 (Onvansertib) in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer
Essai Clinique (Cardiff Oncology)   31 octobre 2023
Nouvel enseignant 2023 : Professeur Jérôme DOYEN
Youtube @ UFR médecine   23 octobre 2023